Stock screenerAll disclosures →
EDGAR →
CUE
Conviction 49HealthcareScan · Tue, Sep 8, 2026Rising three methods
CUE$30.14+9.82%
ResistanceSupportVol 14Insider buyInsider sell9
2
Vol MA14 146.64K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price30.14
Change+9.82%
Gap-0.98%
Rel volume0.99×
Avg volume184.04K
Avg $ vol5.12M
SMA 2027.66
SMA 5029.36
SMA 20013.14
Price vs 50+2.63%
Price vs 200+129.36%
MA stackbullish
50/200 cross—
Supertrenddown · 33.63
RSI (14)55
MACD hist0.34
MACD crossbull · 7d
Stoch %K / %D99 / 70
ADX (14)12
+DI / −DI21 / 14
RSI divergence—
MACD divergence—
ATR %+11.12%
ADR %13.02%
52w high36.78
52w low0.1770
From 52w high-18.07%
Above 52w low+16925.42%
New 52w highNo
SqueezeOn · 15d
Bollinger width36.22%
%B0.75
Donchian pos62.89%
Donchian high34.61
Donchian low22.56
AVWAP (52w high)29.01
vs AVWAP high+3.87%
AVWAP (52w low)2.48
vs AVWAP low+1117.44%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d0.99×
Avg vol (14d)146.64K
Avg vol (20d)184.04K
Avg $ vol (20d)5.12M
Market cap218.91M
RS 3m (vs SPY)-11.28%
RS 6m (vs SPY)+9038.22%
RS line new highNo
Trend template7/8
Technical rank92.5
1 week+18.08%
1 month+11.12%
3 months+3.63%
6 months+9911.63%
1 year+3763.46%
YTD+8831.54%
P/E-8.23
P/B94.77
P/S7.97
P/FCF-10.01
EPS-0.2800
Div yield—
ROE—
ROA-86.63%
Debt/Eq1.73
Current1.25
EV/EBITDA-8.03
Gross margin—
Net margin-96.85%
Rev growth195.75%
EPS growth34.60%
Price target—
Target upside—
Analyst rating—
Institutional23.67%
Ent. value205.52M
Revenue7.88M
Net income-153.07M
Gross profit—
Free cash flow-21.86M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out4.2M
Employees29
ListedTue, Jan 2, 2018
Free float94.71M
Float %97.2%
Short interest327.44K
Days to cover1.6d
Short volume51.3%
Squeeze score16 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction49 / 100
Pattern quality—
Tech rank92.5 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmRising three methods
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CUE
No recent disclosed trades by Congress in CUE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CUE · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Garzone Pamela Director · Common Stock · 2026-07-09 | Grant | 18.9K | — | 2026-07-09 | 2026-08-28 |
Sarraf Pasha Director · Common Stock · 2026-07-09 | Grant | 18.4K | — | 2026-07-09 | 2026-08-28 |
Meluzio Michael Vincent VP, Prin. Accounting Officer · Common Stock · 2026-08-13 | Exercise | 13.65K | — | 2026-08-13 | 2026-08-17 |
Ray Sumita Chief Legal Compliance Officer · Common Stock · 2026-08-13 | Exercise | 18.2K | — | 2026-08-13 | 2026-08-17 |
Ray Sumita Chief Legal Compliance Officer · Common Stock · 2026-08-13 | Sell | 2.38K | $70K | 2026-08-13 | 2026-08-17 |
Ray Sumita Chief Legal Compliance Officer · Common Stock · 2026-08-13 | Sell | 6.44K | $196K | 2026-08-13 | 2026-08-17 |
Ray Sumita Chief Legal Compliance Officer · Common Stock · 2026-08-13 | Sell | 4 | $125 | 2026-08-13 | 2026-08-17 |
Ray Sumita Chief Legal Compliance Officer · Common Stock · 2026-08-13 | Exercise | 18.2K | — | 2026-08-13 | 2026-08-17 |
Meluzio Michael Vincent VP, Prin. Accounting Officer · Common Stock · 2026-08-13 | Sell | 1.52K | $45K | 2026-08-13 | 2026-08-17 |
Meluzio Michael Vincent VP, Prin. Accounting Officer · Common Stock · 2026-08-13 | Sell | 4.11K | $125K | 2026-08-13 | 2026-08-17 |
SEC filings
EDGAR filings in CUE · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.